Prognostic variability in completely resected pN1 non-small-cell lung cancer

Asian Cardiovascular and Thoracic Annals

Volumn 16, Issue 5, 2008, Pages 375-380

  Gonfiotti, Alessandro ^a   Crocetti, Emanuele ^a   Pegna, Andrea Lopes ^a   Paci, Eugenio ^a   Janni, Alberto ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC VARIABILITY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE; TUMOR VOLUME; CANCER STAGING; COMPARATIVE STUDY; ITALY; KAPLAN MEIER METHOD; LUNG RESECTION; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; TIME; TREATMENT OUTCOME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; ITALY; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 55949097075     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230801600507     Document Type: Article

References (18)

1. Koike T, Tsuchiya R, Goya T, Sohara Y, Miyaoka E. Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan. J Thorac Oncol 2007;2: 408-13.
2. Watanabe Y. TNM classification for lung cancer. Ann Thorac Cardiovasc Surg 2003;9:343-50.
3. Okada M, Sakamoto T, Yuki T, Mimura T, Nitanda H, Miyoshi K, et al. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. J Thorac Cardiovasc Surg 2005;129:825-30.
4. Osaki T, Nagashima A, Yoshimatsu T, Tashima Y, Yasumoto K. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer 2004;43:151-7.
5. Riquet M, Manac'h D, Le Pimpec-Barthes F, Dujon A, Chehab A. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg 1999;67: 1572-6.
6. Asamura H, Suzuki K, Kondo H, Tsuchiya R. Where is the boundary between N1 and N2 stations in lung cancer? Ann Thorac Surg 2000;70:1839-46.
7. Rea F, Marulli G, Callegaro D, Zuin A, Gobbi T, Loy M, et al. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2? Lung Cancer 2004;45: 215-20.
8. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-23.
9. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
10. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemnother Rep 1966;50:163-70.
11. Rusch V, Crowley J, Giroux D, Goldstraw P, Im JG, Tsuboi M, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2: 603-12.
12. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-9.
13. Fujimoto T, Cassivi S, Yang P, Barnes S, Nichols F, Deschamps C, et al. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival. J Thorac Cardiovasc Surg 2006;132:499-506.
14. Marra A, Hillejan L, Zaboura G, Fujimoto T, Greschuchna D, Stamatis G. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. J Thorac Cardiovasc Surg 2003;125:543-53.
15. Yano T, Yokoyama H, Inoue T, Asoh H, Tayama K, Ichinose Y. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J Thorac Cardiovascular Surg 1994;107: 1398-402.
16. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 2004;350:351-60.
17. Strauss GM, Herndon JE II, Maddaus MA, Johnstone DW, Johnson EA, Watson DM, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633. ASCO Annual Meeting Proceedings. J Clin Oncol 2006;24(Suppl):7007. Available at: http://meeting.ascopubs.org/cgi/content/abstract/24/ 18_suppl/7007. Accessed February 29, 2008.
18. van Velzen E, Snijder RJ, Brutel de la Rivière A, Elbers HJ, van den Bosch JM. Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Chest 1996;110:1469-73.